Varian Medical Systems, a major manufacturer of integrated cancer therapy systems, is partnering with optx corporation, a leading developer of medical oncology treatment management software. Under the agreement, Varian will begin globally marketing optx
Varian Medical Systems, a major manufacturer of integrated cancer therapy systems, is partnering with optx corporation, a leading developer of medical oncology treatment management software. Under the agreement, Varian will begin globally marketing optx software as a VARiS MedOncology module within its Generation 6 suite of oncology information products. The product will replace earlier versions of Varian’s VARiS MedOncology software. Installation and training for customers, as well as ongoing service and support, will be provided by optx. The optx software will help physicians craft chemotherapy regimens by providing standard and customizable treatment protocols. It will also enable physicians to record treatments and track results.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.